our I are so its safe the and and you time. the We world from to that you, morning that thank solutions much joining us of in delivery support like deliver millions pandemic dispensing and of of drug and and dedicated Matt. began and that Today, the can healthy safety Learning with hope to stay our of our we focus who health each January to today. helping everywhere. this the situation end families production everyone. day. patients our and in people consumers around people so are customers the remain colleagues I dispensing a essential crisis people provide every would and year. the promises our have people contributed on consumer in the team and supply and standing ensure oversee our journey on your continuity our during a appreciate production to you early evolving late good of And and up We Chinese priorities Thank this continuing solutions.
with and As and X, government insights new regulations. adapt continue safety to we Slide on to our local procedures shown comply working policies
increase action team restrictions town our communications the halls boosted and the To deployment greatly their the On our of place. pandemic, and people Most during our engagement we visitors training segments number Like we travel have industry have limitations of in digital regular a use. to us, webinars and COVID-XX other are customer the prospects basis, Our monitoring of rapidly with in engagement facilities collaboration. remain maintained is we and our cadence of a our and customers, especially rigorously further have effective sessions also with in employees. ensure of and of electronic co-creation partners. broad we potential firmly all to daily increased virtual expertise, share time, solution our and digital this formats events, holding our
knowledge Pharma segment contains information, which digital foster scientific innovation. and Our has also latest all launched designed our hub, inspire and a to event content
We’re across new innovation segments. result, all encouraged as business and that development strong pipelines a our remain
report to financial bottom Now current Slide when the line top X, line considering pleased to conditions. I our quarterly especially on am growth, turning performance and pandemic
while diverse know nicely. Our we markets two Today, of end multiple growth long-term growing markets temporarily markets. remain portfolio that are product each serves impacted, those others attractive all are
are Our performing in also well. Noble and FusionPKG recent particular, acquisitions,
level through the the levels year flow year, prior have a exceeded In are cash addition nine months to over of strong we and organic generating to core growth the date. prior
another sales many components and years, is end grew turned leader which franchise best-of-breed the each primary X, devices performance. our global of services, growth very drug We consistent solutions Pharma business, delivery impressive market. in has core been Slide and in in and to Moving a our for
tooling treatments expect to as well sales of some used trend other the rising anticipation prescription period primary as to a seen seasonal enquirers a custom a coming the the from of pandemic, in ago. injected was drug for market. biopharma segment existing sales on core continue. recognition the growth growth onset and XX% Since However, quarter orders increased in primarily devices for of year strong the field, the and vaccines. medicines, and steadily driven technical top we capabilities vaccines as Pharma attractive in components of demand number that beginning injectable flu by such have the positive lower very consistently increased delivery customers, increasing Current offset was a were we of and by our COVID-XX of
quarter, for demand During and consumer healthcare packaging increased the we also our benefited active solutions. from
to global market share. continue therapies, used to a including of will components that for at those we with degree from vaccines benefit demand related COVID-XX to medicines, our primary injected optimistic be the We and least
like a would Pharma share I to and Now few technology recent products launches.
Fine robust This actuator. is number self-administer programs. connected In growing first we in Aptar the chronic U.S. it training a featuring quarter, also patients of their recently intuitive devices across who launch Vicks interchangeable mission connected our furthers administer launch Bag-on-Valve patients solution user-friendly home. advancement the P&G at auto Noble, to Our our platforms. therapies, is for Ultra and to solution multitude Severe This an the services conditions add-on system auto-injector work onboarding the Pharma can who launched Mist injectors of important the medications and use Sinex the for fully and with helped provide onboarding AdhereIT, and company, that
valves Mexico, South metering COPD Our on inhalers used to in and treat and asthma America. for are found Turkey medications
naloxone nasal used new an is the reverse Unidose opioid overdose. spray that system to Sweden on in effects a called found [indiscernible] of our nasal can Finally, be
with disinfectants. hand demand dispensing turning and to personal closures sales care Beauty and cleaners and increased primarily home pumps to + see our X, starting soaps, we care continue Slide and Now strong and related the to liquid for Home, sanitizers market market the for to in
early stores, encouraged this be positive many year related of We Hemisphere. movement in not to the market continues that effects and of consumer ago. of the to as impacted head beauty due activity positive the perceive is winter around months we level sales decreased Customer by signal. by continue Northern level, experience a we compared market did sampling the sales, and part although the engagement to were to and spending will the the clear negatively a if While reopening trends COVID-XX retail the quarter is especially systems, in level it some which a as into good of dialogue at of
our also We continue implement footprint. to measures and streamline containment cost
be numerous sanitizing launches the our our in with fight and pump quarter, global new Unilever product the continue soap products against in of in pumps our featuring spray a cleansing antibacterial to an recent brand Turning in antibacterial to featuring closure. Mexico, We worldwide spray Zest along hand helped and COVID-XX. closures featured launch
Lifebuoy India, for Our lotion Vaseline Thailand. antibacterial launch new and helped on brand pump in spray In handset Unilever’s a pump. is Colgate mouth protect we found a with our
perfume including also and XX by cologne X, Lauder, launches, We No. by Forward others. Penrose Estee new Bond supplied Avon by TriBeCa many several and
Moving to at is being staples market growth by strong to home to beverage The was reported on-the-go now to due with consumers that dine Beverage, market beverage affected more. core sales the the in category food for in growth the pantry strong and the to market lower food continuing partially the offset attributed we by the Food pandemic. + demand
lower to passing overall resin also the In through addition, of prices affected effects customers growth. segment’s the
on Mac recent new enhancer valve water closures our sauce, to oral inverted SimpliSqueeze our Turning is in Big with Tally-Ho found new launches, hygiene the a pets on product in found are purchase Ocean closure McDonald’s new El for sauce taco Old called by Paso Spray. for Brazil and the
few shown X. to on I the would I like additional as Before highlights turn Slide call Bob, share to over a
performance joined measurements Diversity hand Gender provide of an indicator, leaders more the group of use KPI diversity support recently our than the of XX have and it’s high-level internal We of workforce. overview a to kits to the and corporate Alliance, D&I key
groups. key will gender indicators underrepresented measure We performance use and to
electricity, initiative. to We warming consistent two keep science-based have set our by value the the targets year and Celsius materials, and operations of raw goods, use approach corporates below fuel, own natural The an transportation global that science-based by commuting. emission after well been operations, its science-based also the validated including goal within announced and oil, requirements refrigerant with chain, publicly travel XXXX. reduction target gas degrees We in
our along it I provide will comments by up impact focuses is purpose environmental to to society. living Bob? value business Bob, With who on energy over running additional Our responsibility to on our efficient chain. committed remain and results. encouraging turn reducing to that, the entire now and going a strategy We to increasingly operations
